Latigo Biotherapeutics, Inc. Common Stock (LTGO) — Financial Flexibility Index
Latigo Biotherapeutics, Inc. Common Stock (LTGO) has a Financial Flexibility Index of -0.09x as of March 2026. Free cash flow of $-27.07 Million (operating CF $-27.07 Million minus capex $0.00) represents 0% of total liabilities ($303.16 Million). For the full cash flow conversion analysis, see cash efficiency ratio of Latigo Biotherapeutics, Inc. Common Stoc.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Latigo Biotherapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Latigo Biotherapeutics, Inc. Common Stock across 2 annual periods. Also explore LTGO shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Financial Flexibility Index for Latigo Biotherapeutics, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Latigo Biotherapeutics, Inc. Common Stock. Explore Latigo Biotherapeutics, Inc. Common Stoc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-97.42 Million | $-97.56 Million | $307.19 Million | ▲ +5.0% |
| 2024 | -0.33x | $-50.88 Million | $-50.95 Million | $152.46 Million | — |